Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats

Molecular Medicine

Volumn 16, Issue 11-12, 2010, Pages 465-470

  Xing, Shan Shan ^a,b   Bi, Xiu Ping ^a,c   Tan, Hong Wei ^a   Zhang, Yun ^a   Xing, Qi Chong ^d   Zhang, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FRUCTOSE; INTERLEUKIN 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; GENE OVEREXPRESSION; HEART INDEX; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; MALE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FIBROSIS; FRUCTOSE; HEART FAILURE, DIASTOLIC; INTERLEUKIN-18; MALE; RATS; RATS, WISTAR; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 78149244847     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00028     Document Type: Article

References (25)

1. He J, et al. (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch. Intern. Med. 161:996-1002.
2. Grandi AM, et al. (2006) Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. Am. J. Hypertens. 19:199-205.
3. Masugata H, et al. (2006) Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens. Res. 29:897-903.
4. Hung J, McQuillan BM, Chapman CM, Thompson PL, Beilby JP. (2005) Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler. Thromb. Vasc. Biol. 25:1268-73.
5. Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. (1998) Interleukin-18 (IFNgamma -inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14 human blood mononuclear cells. J. Clin. Invest. 101:711-21.
6. Olee T, Hashimoto S, Quach J, Lotz M. (1999) IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J. Immunol. 162:1096-100.
7. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. (1993) Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. Heart Circ. Physiol. 265:H176-82.
8. Finkel MS, et al. (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-9.
9. Kumar A, et al. (1996) Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J. Exp. Med. 183:949-58.
10. Woldbaek PR, et al. (2005) Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am. J. Physiol. Heart Circ. Physiol. 289:H708-14.
11. Xing SS, et al. (2008) Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats. Mol. Med. 14:395-402.
12. Tan HW, et al. (2010) IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome. Atherosclerosis 208:350-7.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A. (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-83.
14. Tei C, Nishimura RA, Seward JB, Tajik AJ. (1997) Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J. Am. Soc. Echocardiogr. 10:169-78.
15. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J. Am. Coll. Cardiol. 30:1527-33.
16. Masson P. (1992) Trichrome stainings and their preliminary technique. J. Tech. Methods 2:75-90.
17. Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, Bariéty J, Michel JB. (1994) Co-localization of myocardial fibrosis and inflammatory cells in rats. Lab. Invest. 70:286-94.
18. Nicoletti A, et al. (1995) Left ventricular fibrosis in renovascular hypertensive rats: effect of losartan and spironolactone. Hypertension 26:101-11.
19. Haller H, et al. (1995) Monocyte infiltration and c-fms expression in hearts of spontaneously hypertensive rats. Hypertension 25:132-8.
20. Esposito K, Giugliano D. (2004) The metabolic syndrome and inflammation: association or causation? Nutr. Metab. Cardiovasc. Dis. 14:228-32.
21. Florez H, et al. (2006) C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res. Clin. Pract. 71:92-100.
22. Reddy VS, et al. (2008) Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J. Cell Physiol. 215:697-707.
23. Kim J, et al. (2006) IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. Biochemical and Biophysical Research Communications 344:1284-9.
24. Wang Y, Li C, Wang X, Zhang J, Chang Z. (2002) Heat shock response inhibits IL-18 expression through the JNK pathway in murine peritoneal macrophages. Biochemical and Biophysical Research Communications 296:742-8.
25. Kim YM, Im JY, Han SH, Kang HS, Choi I. (2000) IFN-gamma up-regulates IL-18 gene expression via IFN consensus sequence-binding protein and activator protein-1 elements in macrophages. J. Immunol. 165:3198-205.